期刊文献+

赤点石斑鱼ICLP基因的克隆和序列分析 被引量:3

Cloning and Sequence Analysis of ICLP from Epinephelus akaara
下载PDF
导出
摘要 MHC class II invariant chain-like proteins(ICLP)因子与免疫反应密切相关,其参与对抗原的处理,保证多肽不被进一步降鹪为氨基酸.通过RACE反应获得赤点石斑鱼ICLP2cDNA全序列,全长1837bp,包括44bp的5’UTR区,861bp的开放阅读框以及932bp的3’UTR区.编码286个氨基酸,推测的蛋白质分子量为31878u.对赤点石斑鱼10个组织的1CLP2基因进行PCR扩增和测序,结果表明赤点石斑鱼ICLP2基因的表达不存在组织特异性.此外,氨基酸序列同源比对的结果表明。赤点石斑鱼与其它16种脊椎动物ICLP2的相似度在25%~78%之间.与狼鲈和鳜鱼ICLP2因子的同源程度最高,分别为78%和74%.根据ICLP的氨基酸序列构建的脊椎动物系统进化树,表明了该分子的氨基酸序列可以作为研究鱼类物种间进化关系的良好指标. The MHC(major histoeompatibility complex molecules)class II invariant chain-like proteins(ICLP)play an important role in the immune response to foreign protein antigens. It can prevent polypeptide from being degraded into amino acids. Using RACE methods, the full-length cDNA of ICLP2 gene from E. akaara was obtained. This full-length eDNA is 1 837 bp, which consists of a 44 bp 5'UTR,a 932 bp 3'UTR( including poly(A))and an 861 bp open reading frame. The predicted protein has 286 amino acids with a molecular weight of 31 878 u. The result also shows that there is no tissue-specific transcript expression of ICLP2 gene in E. akaara. The similarity of the ICLP2 sequence between E. akaara and the other 16 vertibrate animals ranges from 25 % to 78% ,and reveals that E. akaara has the closest relationship with Dicentrarchus labrax and Siniperca chuatsi. The phylogenetic tree constructed in this paper demonstrates that the a mino acid sequences of ICLP gene are potentially informative for phylogenetic studies in fishes.
出处 《厦门大学学报(自然科学版)》 CAS CSCD 北大核心 2009年第3期428-434,共7页 Journal of Xiamen University:Natural Science
基金 福建省自然科学基金(2060203) 福建省高等学校新世纪优秀人才支持计划资助
关键词 赤点石斑鱼 ICLP基因 序列分析 Epinephelus akaara ICLP gene sequence analysis
  • 相关文献

参考文献29

  • 1高明,王海平,王全立.Ⅱ类抗原提呈的分子机制及分子伴侣Ii研究进展[J].微生物学免疫学进展,2004,32(4):70-72. 被引量:3
  • 2Mcconnell T J, Godwin U B, Cuthbertson B J. Expressed major histoeompatibility complex class II loei in fishes [J]. Nature Reviews Immunology, 1998,166 : 294-- 300.
  • 3Heenstra Randall. Groupers of the ,world[M]. Rome: FAO species catalogue, 1993 : 106- 107.
  • 4孟庆闻,缪学祖,俞泰济,等.鱼类学[M].上海:上海科技出版社,1987:9-40.
  • 5Sambrook J,Fritsch E F, Maniatis T, et al. Molecular cloning:a laboratory manual [ M]. 2nd ed. New York:Cold Spring Harbor Lab Press, 1989: 765 --773.
  • 6Zhong D, Yu W, Liu Y, et al. Molecular cloning and expression of two chicken invariant chain isoforms produced by alternative splicing[J ]. Immunogenetics, 2004,56 ( 9 ) : 650--656.
  • 7Dijkstra J M,Kiryu I,Kollner B, et al. MHC class II invariant chain homologues in rainbow trout(Oncorhynchus mykiss ) [ J ]. Fish Shellfish Immunol, 2003, 15 ( 2 ): 91 -- 105.
  • 8Henken D B,Rasooly R S,Javois L,et al. The national institutes of health and the growth of the zebrafish as an experimental model organism[J]. Zebrafish, 2004,1 (2) : 105 --110.
  • 9Yoder J A,Haire R N,Litman G W. Cloning of two zebrafish cDNAs that share domains with the MHC class II-associated invariant chain[J]. Immunogenetics, 1999, 50(1/2) :84--88.
  • 10Sakai M, Kono T, Savan R. Identification of expressed genes in carp(Cyprinus carpio ) head kidney cells after in vitro treatment with immunostimulants[J]. Developmental Biology(Basel) ,2005,121,,45--51.

二级参考文献14

  • 1van Tienhoven EA, ten Brink CT, van Bergen J,et al. Induction of antigen specific CD4+T cell responses by invariant chain based DNA vaccines[J]. Vaccine 2001,19 (11-12):1515-1519.
  • 2Ji H, Chang EY, Lin KY, et al. Antigen-specific immunotherapy for murine lung metastatictumors expressing human papillomavirus type 16 E7 oncoprotein[J]. Int J Cancer 1998,78(1):41-45.
  • 3Fazekas de St Groth B. The evolution of self-tolerance: a new cell arises to meet the challenge of self-reactivity[J]. Immunol Today 1998,19(10):448-454.
  • 4Felix B, Wolfgang W,Christoph W,et al. Specific treatment of autoimmunity with recombinant invariant chain in which CLIP is replaced by self-epitopes[J]. Proc Natl Acad Sci USA 2001,98:12168-12173.
  • 5Moingeon P. Strategies for designing vaccines eliciting Thl responses in humans[J].Journal of Biotechnology 2002,98:189-198.
  • 6Moingeon P, Haensler J, Lindberg A.Towards the rational design of Thl adjuvants[J].Vaccine 2001,19:4363-4372.
  • 7Rengarajan J, Szabo SJ, Glimcher LH.Transcriptional regulation of Thl/Th2 polarization[J].Immunology Today 2000,21:479-483.
  • 8Rovere P, Zimmermann VS, Forquet F, et al. Dendritic cell maturation and antigen presentation in the absence of invariant chain[J]. Proc Natl Acad Sci USA 1998,95(3): 1067-1072.
  • 9Lin KY, Guarnieri FG, Staveley-O'Carroll KF, et al. Treatment of established tumors with a novel vaccine that enhances major histocompatibility class Ⅱ presentation of tumor antigen[J].Cancer Res 1996,56 (1):21-26.
  • 10Malcherek G, Wirblich C, Willcox N, et al. MHC class Ⅱ-associated invariant chain peptide replacement by T cell epitopes:engineered invariant chain as a vehicle for directed and enhanced MHC class Ⅱ antigen processing and presentation[J]. Eur J Immunol

共引文献12

同被引文献48

引证文献3

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部